Results of brain imaging studies demonstrate that "hypnosis influences all of the cortical areas and neurophysiological processes that underlie pain and emotions."
Migraine was more significantly associated with muscle soreness or pain than anxiety disorders in patients with MDD.
Patients in the visual arm of the study wore flashing LED goggles delivering visual stimulation in the alpha-band range.
Evidence indicates that distraction can provide pain relief, highlighting the influence cognitive processes have on pain perception.
The major issues of drug development are that pre-clinical animal efficacy studies do not accurately predict human efficacy, and clinical trials often inaccurately fail to show drug efficacy.
Research on monogenic disorders has made vital contributions to all aspects of medical care, including our understanding of pain pathophysiology.
The recovery time varies depending on which class of medication the patient is overusing.
Connectivity in the right midfrontal gyrus may help predict placebo response. This finding has widespread implications in drug development.
The crystal structure may provide inspiration for designing drugs that refine efficacy and avoid adverse events.
The transfer of hyperalgesia is mediated by olfactory cues in mice, shedding light on the role of social and environmental cues in pain pathogenesis.
Patients with chronic pain often report feeling isolated and misunderstood, or that others believe they are exaggerating their pain or somehow using it to their benefit.
Even when knowing they were taking a placebo, patients still obtained relief from pain.
Dr Twillman, Executive Director for the American Academy of Pain Management, emphasizes the fact that CDC guidelines on opioids are expert- and not evidence-based.
Treating acute pain before it develops into chronic pain may be the key to preventing chronic pain from arising in the first place.
The DEA's plan to list kratom as a Schedule I controlled substance would make researching the possible opioid substitute much more difficult.
The strongest predictor of depression in patients with chronic stable angina was an episode of depression within the past 10 years.
Individuals with a history of abuse experience higher levels of pain, anxiety, and depression.
Researchers discovered novel opioid analgesics, displaying reduced respiratory depression.
Genetic factors and the environment patients share with their partner or spouse may determine their risk of developing chronic pain and help explain the association between chronic pain and depression.
An estimated 20-60% of patients with irritable bowel syndrome (IBS) have comorbid anxiety and/or depression.
Dr Darnall suggests that psychosocial factors are some of the most powerful determinants of pain outcomes.
The findings could have important clinical implications in the treatment of patients with arthritis.
Adolescents who experience chronic pain have higher prevalence of anxiety and depressive symptoms in adulthood.
Optogenetic tools enable light-based modulation of genetically defined neurons and temporally precise stimulation of neural circuit activity.
The Need For a Better Screening Tool
Naloxone is an opioid antagonist that reverses the respiratory depression characteristic of opioid overdose.
In an email interview with Rheumatology Advisor, Louise Sharpe, PhD, spoke about the practical ramifications of her research for clinicians who treat rheumatoid arthritis.
Cognitive Profile and Putative Mechanisms of Cancer Therapy-Associated Cognitive Changes: A Primer for Mental Health Professionals
FDA approves innovative sustained-release drug delivery implant to control opioid dependence for up to 6 months.
Clinicians should focus on treating patients' pain and psychological conditions together.
Psychiatry Advisor Articles
- Sport Psychiatry: An Emerging Specialty
- Clinical Hypnosis May Be Effective for Cancer Pain, IBS, Headaches
- Electroconvulsive Therapy Continues to Be Vital Treatment for Depression in Elderly
- Prolactin-Related Symptoms Decrease with Reduced Risperidone Dosage
- Psilocybin May Provide Swift Relief From Depression, Anxiety in Cancer Patients
- Physical Activity During Midlife Influences Late Life Verbal Memory Performance
- Children With ADHD May Adapt More Poorly To Changes In Positive Reinforcement Patterns
- "Drunkorexia" Linked To Both Eating and Substance Use Disorders
- Updated Depression Screening Recommendations for Adults
- ADHD Symptoms in Adulthood Vary Based on Work Environment
- SPECT Imaging Offers More Accurate Diagnosis of Traumatic Brain Injury
- Medical Students at High Risk for Depression, Suicidal Ideation
- Acute Coronary Syndrome Patients Demonstrate Higher Risk of Suicide
- Psychoeducation No More Effective Than Peer Support at Reducing Time to Next Bipolar Episode
- No Difference Between Omega-3 & Placebo in Patients at Ultrahigh Risk for Psychosis